|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Amortization of intangible assets | |||||
| Unrealized gain on investments | |||||
| Amortization of note receivable premium | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaids and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Advances from related party | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchase of investments | |||||
| Purchase of patents | |||||
| Issuance of note receivable | |||||
| Redemptions of investments | |||||
| Payment of patent purchase obligation - related party | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Contribution from minority member | |||||
| Purchase of treasury stock | |||||
| Proceeds from sale of common stock and warrants, net of issuance costs | |||||
| Proceeds from exercise of warrants | |||||
| Proceeds from sale of Series B preferred stock | |||||
| Net cash provided by financing activities | |||||
| NET INCREASE (DECREASE) IN CASH | |||||
| NET CHANGE IN CASH | |||||
| BEGINNING CASH BALANCE | |||||
| ENDING CASH BALANCE | |||||
| SUPPLEMENTAL CASH FLOW INFORMATION: | |||||
| Cash payments for interest | |||||
| Cash payments for income taxes | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Conversion of management fees and patent liability into common stock | |||||
| Cancellation of Series B preferred stock within accounts payable | |||||
| Cancellation of treasury stock | |||||
Loading...